Biotech Brief ยท NewsmonSignal-driven intelligence briefings for Biotech.https://newsmon.ai/FDA expands gene therapy and cell therapy approvals in sickle cellhttps://newsmon.ai/briefings/biotech/2026-07-03/https://newsmon.ai/briefings/biotech/2026-07-03/FDA approved Casgevy for younger sickle cell patients and TREGZI to improve GVHD outcomes, reinforcing gene/cell therapy momentum.Fri, 03 Jul 2026 00:00:00 GMTbiotechFDA gene therapy leadership shift amid continued regulatory debatehttps://newsmon.ai/briefings/biotech/2026-07-01/https://newsmon.ai/briefings/biotech/2026-07-01/FDA gene therapy leadership is changing as CBER flexibility debates persist, while approvals and manufacturing-focused pilots signal operational evolution for biotech.Wed, 01 Jul 2026 00:00:00 GMTbiotech